Posted On: 12/24/2014 12:21:53 PM
Post# of 30066
Red: I do believe the Lympro data and announcements of LymPro commitments by BP are what will move this stock next. If the data is at least in the high 80s, that will be fine. If it is more in the 92% range or higher that would be fantastic!
Revenue is what moves a stock, but before revenue comes sales. Hopefully Gerald will be able to communicate to us soon how the sales are going. There probably aren't that many new clinical trials starting every month, so AMBS probably has a pretty good handle on each of them.
Revenue is what moves a stock, but before revenue comes sales. Hopefully Gerald will be able to communicate to us soon how the sales are going. There probably aren't that many new clinical trials starting every month, so AMBS probably has a pretty good handle on each of them.
(0)
(0)
